|4Jan 5, 9:38 PM ET

COLLIER RICHARD T 4

4 · PROTHENA CORP PUBLIC LTD CO · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-055,0000 total
    Exercise: $6.41From: 2014-01-29Exp: 2023-01-29Ordinary Shares (5,000 underlying)
  • Sale

    Ordinary Shares, par value $0.01 per share

    2023-01-05$52.67/sh5,000$263,3501,219 total
  • Exercise/Conversion

    Ordinary Shares, par value $0.01 per share

    2023-01-05$6.41/sh+5,000$32,0506,219 total
Footnotes (3)
  • [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $52.215 to $53.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4.
  • [F3]The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4